SkinBioTherapeutics plc (SBTX) Ord GBP0.01

- Add to watchlist
- Create an alert
- This stock can be held in a




25.50p
26.00p
27.50p
£55.09 million
25.50p
23.00p
8.50p
n/a
0.60p (2.30%) Previous:
0.60p
2,422,802
n/a
30,000
Performance
1 week 1W | 20% | 1 year 1Y | 175.68% |
---|---|---|---|
1 month 1M | 6.25% | 2 years 2Y | 64.52% |
3 months 3M | 43.66% | 3 years 3Y | 5.9% |
6 months 6M | 37.84% | 5 years 5Y | 44.04% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 30/06/2024 | 30/06/2023 |
---|---|---|
Revenue (£m) | 1.21 | 0.13 |
Profit before tax (£m) | (2.95) | (3.01) |
Adjusted EPS (p): | (1.54) | (1.72) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
SkinBioTherapeutics shares jump on acquisition of topical cream maker
11 October 2024 08:41
-
SkinBioTherapeutics reports positive results from testing with Croda
19 September 2024 13:13
-
SkinBioTherapeutics secures £1.56m from new investors
2 August 2024 14:57
-
Board Appointment Confirmation
28 April 2025 07:00
-
Warrant Exercise Notice and Total Voting Rights
28 April 2025 07:00
-
Board and Leadership Changes
24 April 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.